Former Wisconsin Badger and NFL player Rodney Lossow is coaching again at Minneapolis Roosevelt after needing to step away ...

Researchers at the Technical University of Munich (TUM) have linked mitochondrial dysfunctions to Crohn’s disease, ...

Changes in the way clinicians care for Crohn’s disease patients are now being made across the world, thanks to a ...

Today, there is an alarming trend in diagnoses of Crohn's Disease in Black populations? Here is why and what you need to ...

On a mission to collect a key Crohn’s disease approval and build out its inflammatory bowel disease (IBD) profile, Eli Lilly ...

At 52 weeks of follow-up, more patients on Eli Lilly’s monoclonal antibody Omvoh demonstrated histologic response, suggesting ...

Stelara is one of the most successful Crohn’s therapies, generating $10.8bn last year, Lilly hopes to introduce Omvoh as its ...

Eli Lilly and Company (NYSE: LLY) announced data demonstrating more patients with moderately to severely active Crohn's ...

Patients with inflammatory bowel disease (IBD) who initially responded to the investigational monoclonal antibody ...

(RTTNews) - Eli Lilly and Company (LLY) Monday announced 1-year histologic data from the Phase 3 VIVID-1 study of mirikizumab in people with Crohn's disease, a type of inflammatory bowel disease.

Lilly announces positive results from phase 3 study of mirikizumab compared to ustekinumab for Crohn's disease: Indianapolis Tuesday, October 15, 2024, 18:00 Hrs [IST] Eli Lilly a ...

Disruptions of mitochondrial functions have a fundamental influence on Crohn's disease. This connection has now been ...